Form 4: Tectonic Therapeutic Executive Sells Shares
Insider Transaction (Form 4)
Peter Mcnamara, Chief Scientific Officer of Tectonic Therapeutic, Inc., sold 43 shares of common stock on August 12, 2026 for $35.00 per share.
Summary
- Option exercise/conversion: acquired 43 Common Stock at $14.71 ($633) on August 12, 2026; holds 55,328 after (Direct).
- Open-market sale: disposed of 43 Common Stock at $35.00 ($1,505) on August 12, 2026; holds 55,285 after (Direct).
- Option exercise/conversion: disposed of 43 Employee Stock Option (Right to Buy) on August 12, 2026; holds 7,830 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $1,505 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Peter Mcnamara — Officer (Chief Scientific Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-12 | Option exercise/conversion | Common Stock | 43 | $15 | $633 | 55,328 |
| 2026-08-12 | Open-market sale | Common Stock | 43 | $35 | $1.5K | 55,285 |
| 2026-08-12 | Option exercise/conversion | Employee Stock Option (Right to Buy) | 43 | — | — | 7,830 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-12 | Option exercise/conversion (43 shares) |
| 2026-08-12 | Open-market sale (43 shares) |
| 2026-08-12 | Option exercise/conversion (43 shares) |
Keywords
insider transaction, Form 4, TECX, Tectonic Therapeutic, Inc., bearish, Peter Mcnamara
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.